2.60
Cronos Group Inc stock is traded at $2.60, with a volume of 2.79M.
It is up +1.56% in the last 24 hours and up +21.50% over the past month.
Cronos Group Inc headquartered in Toronto, Canada, cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis primarily to Israel. In the U.S., the company has an option to acquire 5.9% of U.S. multistate operator PharmaCann on a fully diluted basis upon easing of federal prohibition.
See More
Previous Close:
$2.56
Open:
$2.55
24h Volume:
2.79M
Relative Volume:
1.45
Market Cap:
$995.90M
Revenue:
$87.89M
Net Income/Loss:
$-73.96M
P/E Ratio:
-14.11
EPS:
-0.1843
Net Cash Flow:
$-46.26M
1W Performance:
+9.70%
1M Performance:
+21.50%
6M Performance:
+31.98%
1Y Performance:
+12.55%
Cronos Group Inc Stock (CRON) Company Profile
Name
Cronos Group Inc
Sector
Phone
(416) 504-0004
Address
4491 CONCESSION RD 12, STAYNER, ON
Compare CRON with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
CRON
Cronos Group Inc
|
2.60 | 968.84M | 87.89M | -73.96M | -46.26M | -0.1843 |
![]()
ZTS
Zoetis Inc
|
156.62 | 67.51B | 9.39B | 2.62B | 2.22B | 5.81 |
![]()
TAK
Takeda Pharmaceutical Co Adr
|
15.52 | 47.88B | 29.96B | 957.25M | 4.77B | 0.304 |
![]()
HLN
Haleon Plc Adr
|
9.82 | 43.42B | 14.26B | 1.98B | 2.47B | 0.4347 |
![]()
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
18.46 | 20.72B | 16.70B | -157.13M | 1.19B | -0.155 |
![]()
UTHR
United Therapeutics Corp
|
312.23 | 14.21B | 2.99B | 1.21B | 1.13B | 25.06 |
Cronos Group Inc Stock (CRON) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Nov-02-22 | Initiated | Bernstein | Mkt Perform |
Jul-28-22 | Upgrade | Canaccord Genuity | Hold → Buy |
May-11-22 | Upgrade | CIBC | Neutral → Sector Outperform |
Mar-22-22 | Upgrade | Barclays | Underweight → Equal Weight |
Jan-27-22 | Upgrade | Jefferies | Underperform → Hold |
Nov-18-21 | Resumed | BofA Securities | Underperform |
Apr-28-21 | Resumed | BofA Securities | Underperform |
Feb-22-21 | Downgrade | CIBC | Sector Outperform → Neutral |
Jun-24-20 | Upgrade | Raymond James | Mkt Perform → Outperform |
Apr-27-20 | Downgrade | Raymond James | Outperform → Mkt Perform |
Apr-14-20 | Downgrade | Piper Sandler | Overweight → Neutral |
Apr-02-20 | Downgrade | BofA/Merrill | Buy → Neutral |
Mar-31-20 | Downgrade | Canaccord Genuity | Hold → Sell |
Mar-04-20 | Upgrade | MKM Partners | Neutral → Buy |
Mar-03-20 | Downgrade | Stifel | Buy → Hold |
Oct-18-19 | Upgrade | Stifel | Hold → Buy |
Sep-20-19 | Initiated | MKM Partners | Neutral |
Sep-05-19 | Upgrade | BMO Capital Markets | Underperform → Market Perform |
Aug-13-19 | Initiated | Piper Jaffray | Overweight |
Aug-09-19 | Upgrade | Canaccord Genuity | Sell → Hold |
Jun-28-19 | Initiated | Consumer Edge Research | Equal Weight |
Jun-06-19 | Initiated | Stifel | Hold |
Jun-05-19 | Upgrade | BofA/Merrill | Underperform → Buy |
Apr-17-19 | Initiated | BofA/Merrill | Underperform |
Mar-27-19 | Downgrade | Canaccord Genuity | Hold → Sell |
Feb-25-19 | Initiated | Jefferies | Underperform |
Jan-18-19 | Initiated | CIBC | Sector Outperform |
View All
Cronos Group Inc Stock (CRON) Latest News
Cronos Group Inc. (CRON) Invests $30M in High Tide to Fuel Canadian Cannabis Retail Expansion - MSN
Cronos grows international footprint in Switzerland - MSN
Cronos Group (CRON) Posts Double-Digit Cannabis Growth and Expands International Footprint - MSN
Cronos Group (CRON.O): Unpacking a Sharp 5.7% Intraday Move Amid Quiet Fundamentals - AInvest
Watch for Bullish Crossover in Cronos Group Inc.July 2025 Gainers & Daily Stock Trend Watchlist - kangso.co.kr
Is Cronos Group Inc. forming a double bottomJuly 2025 Earnings & Safe Entry Point Identification - newsyoung.net
Why Cronos Group Inc. stock attracts strong analyst attentionJuly 2025 Selloffs & Comprehensive Market Scan Insights - 선데이타임즈
Will CRONOS GROUP INC COM NPV (OTCMKTS:PRMCF) Vertical Integration Strategy Lead To New Highs? - Insider Financial
Cronos Group Inc. (NASDAQ:CRON) Q2 2025 Earnings Call Transcript - MSN
What are Cronos Group Inc.’s earnings expectationsPortfolio Update Summary & Daily Volume Surge Trade Alerts - thegnnews.com
Cronos Group Inc.'s (TSE:CRON) 26% Share Price Surge Not Quite Adding Up - simplywall.st
Cronos Group’s Earnings Call Highlights Growth and Expansion - MSN
Cronos Group Inc.’s Beta Climbs After Market VolatilityJuly 2025 Gainers & Precise Swing Trade Alerts - classian.co.kr
Can Cronos Group Inc. Regain Lost Ground This Quarter2025 Key Highlights & Safe Entry Momentum Tips - beatles.ru
What Does Cronos Group’s Revenue Growth and Rising Losses Reveal About Its Strategic Direction (TSX:CRON)? - simplywall.st
Cronos Group Reports 21% Revenue Growth, Strong Gross Margin Improvement and International Expansion. - AInvest
Cronos Group (CRON.O) Suffers Unusual Intraday Slide – What’s Behind It? - AInvest
Cronos Group stock hits 52-week high at 2.72 USD - Investing.com
Cronos Group Reports Strong Q2 2025 Performance - TipRanks
Cronos stock rises on second quarter revenue growth - MSN
Cronos Group and the Cannabis Rescheduling Catalyst: Strategic Positioning in a Regulatory-Transforming Market - AInvest
Cronos Group Surges 15% Amid Trump Administration's Rescheduling Consideration - AInvest
Cronos Rallies Amidst Greater Cannabis Sector Rally Over Possible Rescheduling (CRON) - Seeking Alpha
CRON Soars 15% on Trump Marijuana Reclassification Hints and Q2 Earnings Surge – What’s Next? - AInvest
Is Cronos Group’s Stock Set to Surge? - StocksToTrade
Cronos Group is an undervalued stock, Roth says - Cantech Letter
Cronos Group (CRON.O) Sharp Intraday Move: What’s Behind the Surge? - AInvest
Exploring Three Undiscovered Gems in Canada with Strong Potential - Yahoo Finance
Cronos Group Soars 20.87% on Trump's Marijuana Reclassification Hopes - AInvest
Is Cronos Group Inc. gaining market shareBest Stocks for Explosive Gains - mustnews.co.kr
Cronos Group 2025 Q2 Earnings Deepening Losses Despite Revenue Growth - AInvest
Cronos Group shares fall 1.76% intraday after Q2 2025 earnings call. - AInvest
Cronos Group Appoints New Principal Accounting Officer - The Globe and Mail
Cronos: Q2 Earnings Snapshot - Connecticut Post
Cronos Group signals expanded GrowCo capacity to drive growth amid 21% revenue increase - MSN
Cronos Group's Q2 2025: Unpacking Contradictions in Gross Margins, GrowCo Expansion, and Market Performance - AInvest
Cronos Group sees strong growth in international sales, but increased losses in Q2 2025 - StratCann
Cronos Group (CRON.O) Sees Sharp Intraday Move—What’s Behind It? - AInvest
Cronos Group Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Cronos stock rises on second quarter revenue growth (CRON) - Seeking Alpha
Earnings call transcript: Cronos Group Q2 2025 reveals revenue growth amid EPS miss By Investing.com - Investing.com South Africa
Earnings call transcript: Cronos Group Q2 2025 reveals revenue growth amid EPS miss - Investing.com Canada
Earnings Snapshot: Cronos misses Q2 top-line and bottom-line estimates - MSN
Cronos Group Reports 2025 Second Quarter Results - The Manila Times
Cronos Group Inc Stock (CRON) Financials Data
Revenue
Net Income
Cash Flow
EPS
Cronos Group Inc Stock (CRON) Insider Trading
Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
---|---|---|---|---|---|---|---|
Weigensberg Arye | See Remarks |
May 12 '25 |
Option Exercise |
0.00 |
9,014 |
0 |
129,469 |
Weigensberg Arye | See Remarks |
May 10 '25 |
Option Exercise |
0.00 |
3,118 |
0 |
120,455 |
Wagner Adam | SVP, Head of Cronos Israel |
May 12 '25 |
Option Exercise |
0.00 |
6,276 |
0 |
57,435 |
Wagner Adam | SVP, Head of Cronos Israel |
May 10 '25 |
Option Exercise |
0.00 |
20,468 |
0 |
51,159 |
GORENSTEIN MICHAEL RYAN | See remarks below |
Mar 21 '25 |
Option Exercise |
0.00 |
3,000,000 |
0 |
13,689,272 |
Weigensberg Arye | See Remarks |
Mar 15 '25 |
Option Exercise |
0.00 |
24,236 |
0 |
117,337 |
Shlimak Anna | See Remarks |
Mar 15 '25 |
Option Exercise |
0.00 |
75,226 |
0 |
265,198 |
JACOBSON JEFFREY DAVID | Chief Growth Officer |
Mar 15 '25 |
Option Exercise |
0.00 |
90,957 |
0 |
387,271 |
Holm James | Chief Financial Officer |
Mar 15 '25 |
Option Exercise |
0.00 |
96,724 |
0 |
230,324 |
GORENSTEIN MICHAEL RYAN | See remarks below |
Mar 15 '25 |
Option Exercise |
0.00 |
355,900 |
0 |
10,789,384 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):